Introduction
Tezspire (tezepelumab-ekko) is a human IgG2λ monoclonal antibody used as add-on maintenance treatment for severe asthma and inadequately controlled chronic rhinosinusitis with nasal polyps. It is approved for adults and pediatric patients 12 years of age and older.
For patients managing ongoing respiratory conditions, the cost and administrative requirements associated with prescription treatment can create additional challenges. Prescription Hope may help eligible patients navigate medication assistance options and seek access to prescribed medications such as Tezspire.
What Is the Tezspire Patient Assistance Program?
Understanding Tezspire Prescription Assistance
Patient assistance programs may help eligible patients who have difficulty affording prescribed medications. Prescription Hope provides support for patients seeking medication assistance and can help simplify the process of navigating applicable assistance programs.
Eligibility requirements vary by program. Patients may need to provide information about their prescription, insurance status, income, and other circumstances. Prescription Hope advocates can help patients understand the application process and coordinate the information needed to seek assistance.
How Expert Advocates Help Make Tezspire More Affordable
Personalized Medication Assistance
Prescription Hope advocates can help eligible patients navigate the process of seeking medication assistance for Tezspire. This may include helping patients understand application requirements, gathering necessary documentation, and coordinating information between the patient, healthcare provider, and applicable assistance program.
Personalized assistance can make the administrative process easier to navigate while patients focus on managing their treatment.
Ongoing Patient Support
Seeking medication assistance may involve more than completing an initial application. Patients may need continued support with documentation, renewals, or other program requirements.
Prescription Hope provides ongoing support to help eligible patients navigate these requirements and continue seeking access to prescription medications when applicable program criteria are met.
Tezspire Price Comparison
vs
Estimated Retail Price*
30-Day Supply
Prescription Hope Price
Per Month, NO Matter The Retail Price
*Source: Drugs.com
Navigating Treatment Costs
The cost of ongoing treatment can be an additional concern for patients managing severe asthma or inadequately controlled CRSwNP. Prescription Hope may help eligible patients navigate medication assistance options for Tezspire.
Prescription Hope’s service is available at $70.00 per month, per medication. Patients must still meet the applicable requirements for medication assistance.
Tezspire Patient Assistance Eligibility
General Eligibility Requirements
Eligibility for medication assistance varies by program. General factors that may be considered include income, insurance status, having a valid prescription, and U.S. residency.
Prescription Hope can help patients understand the information that may be required when seeking assistance. Submitting an application does not guarantee approval, and patients must meet the requirements of the applicable assistance program.
Simple Enrollment With Expert Support
Getting Started With Enrollment
Prescription Hope helps simplify the process of seeking prescription assistance by guiding patients through the necessary steps:
- Submit Information: Provide the information needed to begin the assistance process.
- Advocate Contact: A Prescription Hope advocate reviews the information and helps explain the next steps.
- Document Collection: Gather the required patient and prescription documentation.
- Provider Coordination: Prescription Hope may coordinate with the healthcare provider when additional information is needed.
- Program Submission: Required materials are submitted to the applicable medication assistance program.
- Medication Delivery: If the patient qualifies and the application is approved, the medication can proceed through the applicable fulfillment process.
Understanding Tezspire
How Tezspire Works
Tezspire contains tezepelumab-ekko, a thymic stromal lymphopoietin (TSLP) blocker and human IgG2λ monoclonal antibody.
Tezepelumab-ekko binds to TSLP, an epithelial-cell-derived cytokine involved in initiating and maintaining airway inflammation. By blocking TSLP activity, Tezspire interferes with multiple inflammatory pathways involved in severe asthma and chronic rhinosinusitis with nasal polyps. The precise mechanism by which TSLP inhibition produces clinical effects has not been fully established.
What Conditions Does Tezspire Treat?
Tezspire is indicated as add-on maintenance treatment for severe asthma in adults and pediatric patients 12 years of age and older. It is also indicated for inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adults and pediatric patients 12 years of age and older.
For asthma, Tezspire is not indicated for the relief of acute bronchospasm or treatment of status asthmaticus.
Benefits of Treatment
In the NAVIGATOR trial, Tezspire significantly reduced the annualized rate of clinically significant asthma exacerbations compared with placebo. The annualized exacerbation rate was 0.93 with Tezspire compared with 2.10 with placebo. Improvements in lung function were also observed, with improvement in FEV1 occurring as early as 2 weeks in NAVIGATOR.
For inadequately controlled CRSwNP, the WAYPOINT trial demonstrated improvements in nasal polyp score, nasal congestion, and loss of smell. This medication reduced the proportion of patients requiring sinonasal surgery or systemic corticosteroids by 92% compared with placebo over 52 weeks. It reduced the proportion requiring sinonasal surgery by 98% and those requiring systemic corticosteroids by 88%.
Important Safety Information and Side Effects
Tezspire does not have a boxed warning. However, the medication has important warnings and precautions that should be discussed with a healthcare professional.
Hypersensitivity Reactions
Hypersensitivity reactions, including rash and allergic conjunctivitis, have occurred with this medication. Postmarketing cases of anaphylaxis have also been reported. Reactions may occur within hours of administration or have a delayed onset.
Acute Asthma Symptoms or Deteriorating Disease
Tezspire should not be used to treat acute asthma symptoms, acute exacerbations, acute bronchospasm, or status asthmaticus.
Abrupt Corticosteroid Reduction
Systemic or inhaled corticosteroids should not be discontinued abruptly when Tezspire is initiated. Any reduction should be gradual and performed under appropriate medical supervision.
Parasitic Infections
Patients with pre-existing helminth infections should be treated before starting this medication. If a helminth infection develops during treatment and does not respond to anti-helminth therapy, Tezspire should be discontinued until the infection resolves.
Live Vaccines
Live attenuated vaccines should be avoided during treatment because concomitant use with this medication has not been evaluated.
Contraindications
Tezspire is contraindicated in patients with known hypersensitivity to tezepelumab-ekko or any of its excipients.
Pregnancy and Breastfeeding
There are no available human data sufficient to evaluate the risk of major birth defects, miscarriage, or other adverse maternal or fetal outcomes. Tezepelumab-ekko crosses the placenta in animal studies, but no evidence of fetal harm was observed in a monkey study at exposures substantially above the human recommended dose.
There are no data regarding the presence of tezepelumab-ekko in human milk or its effects on breastfed infants or milk production. The benefits of breastfeeding should be considered together with the mother’s clinical need for Tezspire and any potential effects on the breastfed infant.
Common Side Effects
For severe asthma, the most common adverse reactions occurring in 3% or more of patients and more frequently than placebo include:
- Pharyngitis
- Arthralgia
- Back pain
For CRSwNP, common adverse reactions occurring in 3% or more of patients and more frequently than placebo include:
- Nasopharyngitis
- Upper respiratory tract infection
- Epistaxis
- Pharyngitis
- Back pain
- Influenza
- Injection-site reactions
- Arthralgia
Postmarketing cases of anaphylaxis have also been reported.
Access to Multiple Medications
Support Beyond Tezspire
Patients seeking assistance with Tezspire may also need support accessing other prescription medications. Prescription Hope can help eligible patients navigate medication assistance options beyond a single prescription.
Why Choose Prescription Hope for Brand-Name Medication Assistance
Patient-Focused Medication Support
Prescription Hope provides patient-focused support for people seeking assistance with prescription medications. Advocates can help eligible patients navigate the application process and understand the information needed to seek medication assistance.
Simplified Access to Specialty Therapies
Tezspire is a biologic therapy used as an add-on maintenance treatment for severe asthma and inadequately controlled CRSwNP. Prescription Hope may help eligible patients simplify the process of seeking medication assistance by providing guidance and support throughout the application process.
Ongoing Prescription Assistance
Prescription Hope’s support can extend beyond the initial application process. Eligible patients may receive ongoing assistance as they navigate documentation, renewals, and other requirements associated with prescription assistance.
For patients prescribed Tezspire, this support can simplify the administrative process of seeking medication assistance while they focus on their treatment.
If you need access to affordable Tezspire, then be sure to enroll with Prescription Hope today!